Philippe Pierre-St
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Renal tubule-specific Atgl deletion links kidney lipid metabolism to glucagon-like peptide 1 and insulin secretion independent of renal inflammation or lipotoxicity.
Journal: Molecular metabolism
Published: January 22, 2024
Gut microbiota and fermentation-derived branched chain hydroxy acids mediate health benefits of yogurt consumption in obese mice.
Journal: Nature communications
Published: July 19, 2021
Dietary fat and low fiber in purified diets differently impact the gut-liver axis to promote obesity-linked metabolic impairments.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: April 21, 2021
Cholecalciferol Supplementation Does Not Prevent the Development of Metabolic Syndrome or Enhance the Beneficial Effects of Omega-3 Fatty Acids in Obese Mice.
Journal: The Journal of nutrition
Published: September 13, 2020
A polyphenol-rich cranberry extract protects against endogenous exposure to persistent organic pollutants during weight loss in mice.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: August 18, 2020
Blueberry proanthocyanidins and anthocyanins improve metabolic health through a gut microbiota-dependent mechanism in diet-induced obese mice.
Journal: American journal of physiology. Endocrinology and metabolism
Published: April 02, 2020
Feeding diversified protein sources exacerbates hepatic insulin resistance via increased gut microbial branched-chain fatty acids and mTORC1 signaling in obese mice.
Journal: Nature communications
Published: March 06, 2020
Inhibition of mitochondrial complex 1 by the S6K1 inhibitor PF-4708671 partly contributes to its glucose metabolic effects in muscle and liver cells.
Journal: The Journal of biological chemistry
Published: March 18, 2019
Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.
Journal: Diabetologia
Published: September 25, 2017
Loss of OcaB Prevents Age-Induced Fat Accretion and Insulin Resistance by Altering B-Lymphocyte Transition and Promoting Energy Expenditure.
Journal: Diabetes
Published: May 15, 2017
Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.
Journal: Diabetes, obesity & metabolism
Published: July 24, 2016
Last Updated: 09/26/2026